DeCode
DeCode Genetics
DeCode?s genotyping facility is located in its headquarters in Reykjavik, Iceland.
Illumina has certified DeCode Genetics to use its Infinium BeadChip genotyping platform.
To become a certified service provider for Illumina?s Infinium tool, DeCOde passed a two-phase process that included data generation and data certification, and underwent on-site audits of processes and facilities.
DeCode will use the BeadChip platform in conjunction with its Disease Miner software and other disease-related IP to develop DNA-based diagnostics and to offer expanded contract genotyping services to its customers.
DeCode and Illumina last May signed an agreement to develop and market molecular diagnostics for type II diabetes, breast cancer and heart attack.